Literature DB >> 12544706

Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature.

Stephan Rüegg1, Stefan Engelter, Christine Jeanneret, Andreas Hetzel, Alphonse Probst, Andreas J Steck, Philippe Lyrer.   

Abstract

Giant cell arteritis (GCA) is known to affect the extracranial part of the vertebral arteries. Bilateral vertebral artery occlusion (BVAO) is a rare but serious neurologic condition. We report 3 patients with autopsy-proven (2 patients) or clinically diagnosed (1 patient) GCA causing BVAO. A review of the literature concerning BVAO revealed 5 other cases of BVAO resulting from GCA and 110 cases with underlying arteriosclerotic disease. Our 3 patients (mean age, 66 yr; range, 60-78 yr) with BVAO resulting from GCA all had initial severe headache followed by the onset of stepwise progressive, partly side-alternating neurologic deficits due to bilateral infarctions in the vertebrobasilar circulation territory. This course, more accelerated in BVAO due to GCA than in BVAO of arteriosclerotic origin, seems to be a typical, if not particular, clinical syndrome. BVAO was the first clinical manifestation of GCA in 1 of our patients and in 1 published case. From a clinical view, BVAO resulting from GCA differs from BVAO of arteriosclerotic origin by the much higher mortality rate (75% versus 19%, respectively), the presence of headache (100% versus 22%), fever (50% versus 0%), and elevated erythrocyte sedimentation rate (ESR in all GCA cases >45 mm/h; no data in the arteriosclerotic patient group), but not by the neurologic signs themselves. Therapy of BVAO resulting from GCA is purely empiric. In view of the serious prognosis, we propose treatment with intravenous high-dose glucocorticoids and additional immunosuppression with cyclophosphamide; the use of anticoagulation depends on the individual patient's estimated risk-benefit profile. Although BVAO due to GCA is rare, physicians and especially rheumatologists or neurologists should be aware of this entity because of its high mortality in patients without immediate introduction of a high-dose immunosuppressive therapy. Suspicion of GCA should arise in a patient aged over 50 years with no other vascular risk factors suffering from bilateral symptoms of ischemia in the vertebrobasilar territory, with a quickly progressing stepwise course and with headache, fever, or history of myalgia. ESR and temporal artery biopsy should be performed without delay. Early diagnosis of GCA is necessary for immediate initiation of intensive antiinflammatory and immunosuppressive treatment, without which progressive deterioration and systemic involvement are likely to be fatal.

Entities:  

Mesh:

Year:  2003        PMID: 12544706     DOI: 10.1097/00005792-200301000-00001

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  23 in total

Review 1.  Giant cell arteritis.

Authors:  J M Calvo-Romero
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

2.  Bilateral vertebral giant cell arteritis--favourable outcome in two cases.

Authors:  R Sutter; S Renaud; L Bonati; P Lyrer; M Tolnay; S Wetzel; S Rüegg; S Engelter
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

3.  [Brain stem infarction, temporal headache, and elevated inflammatory parameters in a 74-year-old man].

Authors:  M Gehlen; M Schwarz-Eywill; N Schäfer; A Pfeiffer; H Bösenberg; A Maier; C Hinz
Journal:  Internist (Berl)       Date:  2016-06       Impact factor: 0.743

Review 4.  An atypical presentation of giant cell arteritis.

Authors:  Jocelyn Zwicker; Edward J Atkins; Cheemun Lum; Mukul Sharma
Journal:  CMAJ       Date:  2011-02-07       Impact factor: 8.262

Review 5.  Giant cell arteritis: Current treatment and management.

Authors:  Cristina Ponte; Ana Filipa Rodrigues; Lorraine O'Neill; Raashid Ahmed Luqmani
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

6.  [Clinical aspects of temporal arteritis: course variations up to fatal complications].

Authors:  A Brüggemann; K Holl-Ulrich; M Müller
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

Review 7.  The Treatment of Giant Cell Arteritis.

Authors:  Imran Jivraj; Madhura Tamhankar
Journal:  Curr Treat Options Neurol       Date:  2017-01       Impact factor: 3.598

8.  [Multiple ischemic vertebrobasilar lesions in temporal arteritis].

Authors:  S Haas; T Jürgens; B Vatankhah; S Schwarz; G Schuierer; U Bogdahn; A Steinbrecher
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

9.  Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis.

Authors:  Thierry Zenone; Marie Puget
Journal:  Rheumatol Int       Date:  2013-07-20       Impact factor: 2.631

10.  3-T MRI detects inflammatory stenosis of the vertebral artery in giant cell arteritis.

Authors:  J Geiger; M Uhl; H H Peter; M Langer; T A Bley
Journal:  Clin Rheumatol       Date:  2008-01-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.